More on CRL
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $339.66 |
|
|||
| Open | $337.78 | ||||
| 52 Wk High | $89.18 | ||||
| 52 Wk Low | $65.70 | ||||
| Day High | $347.20 | ||||
| Day Low | $332.17 | ||||
| P/E | 160.64 | ||||
| EPS | $2.15 | ||||
| Volume | 822,296 | ||||
- Form 4 CHARLES RIVER LABORATORI For: Oct 21 Filed by: Parisotto Shannon M
- Charles River, Labcorp, and FDA sign drug abuse potential research pact
- Charles River, Labcorp, and FDA Collaborate to Validate New Preclinical Methods for Abuse Potential Assessment
- Form 144 CHARLES RIVER LABORATORI Filed by: FOSTER JAMES C
- Form 144 CHARLES RIVER LABORATORI Filed by: Parisotto Shannon M
- Charles River Labs (CRL) PT Raised to $340 at Morgan Stanley
- Charles River Collaborates with Magellan Stem Cells to Advance Stem Cell and Regenerative Medicine Development
- Charles River Laboratories Schedules Third-Quarter 2026 Earnings Release and Conference Call
- Form 4 CHARLES RIVER LABORATORI For: Oct 05 Filed by: Parisotto Shannon M
- Charles River and Autolomous Partner to Transform Laboratory Execution Systems
Entities mentioned with CRL
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Jefferies & Co | View Related Stories »
- 13G | View Related Stories »
- Show More...
